A detailed history of Newfound Research LLC transactions in Incyte Corp stock. As of the latest transaction made, Newfound Research LLC holds 1,187 shares of INCY stock, worth $79,600. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,187
Previous 876 35.5%
Holding current value
$79,600
Previous $67,000 17.91%
% of portfolio
0.19%
Previous 0.14%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 13, 2022

BUY
$66.18 - $82.86 $20,581 - $25,769
311 Added 35.5%
1,187 $79,000
Q2 2022

Jul 15, 2022

BUY
$66.18 - $83.18 $57,973 - $72,865
876 New
876 $67,000
Q1 2022

May 04, 2022

SELL
$66.02 - $79.71 $88,004 - $106,253
-1,333 Closed
0 $0
Q4 2021

Jan 19, 2022

SELL
$63.34 - $74.11 $7,347 - $8,596
-116 Reduced 8.01%
1,333 $98,000
Q3 2021

Oct 14, 2021

BUY
$68.67 - $84.02 $29,459 - $36,044
429 Added 42.06%
1,449 $100,000
Q2 2021

Jul 19, 2021

BUY
$79.87 - $87.53 $9,185 - $10,065
115 Added 12.71%
1,020 $86,000
Q1 2021

Apr 28, 2021

SELL
$76.02 - $100.5 $26,835 - $35,476
-353 Reduced 28.06%
905 $74,000
Q4 2020

Jan 22, 2021

BUY
$80.74 - $97.7 $75,734 - $91,642
938 Added 293.13%
1,258 $109,000
Q3 2020

Oct 20, 2020

BUY
$85.07 - $109.69 $27,222 - $35,100
320 New
320 $29,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $14.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Newfound Research LLC Portfolio

Follow Newfound Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newfound Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Newfound Research LLC with notifications on news.